Five probable factors responsible for the COVID-associated mucormycosis outbreak in India

The second wave of COVID-19 due to the delta variant (B.1.617.2) led to a rapid rise in total coronavirus and COVID-associated mucormycosis cases reported from India. Hence, our study explored the possible causes of a rapid upsurge in COVID-associated mucormycosis, which has accounted for over 70% o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Khaiwal Ravindra, Ajit Ahlawat
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	COVID-19 COVID-associated mucormycosis diabetes mellitus steroid overdose awareness Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/5f79c437ea8847149284f53d389a5a76
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5f79c437ea8847149284f53d389a5a76
record_format	dspace
spelling	oai:doaj.org-article:5f79c437ea8847149284f53d389a5a762021-11-30T04:14:22ZFive probable factors responsible for the COVID-associated mucormycosis outbreak in India1201-971210.1016/j.ijid.2021.09.057https://doaj.org/article/5f79c437ea8847149284f53d389a5a762021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007657https://doaj.org/toc/1201-9712The second wave of COVID-19 due to the delta variant (B.1.617.2) led to a rapid rise in total coronavirus and COVID-associated mucormycosis cases reported from India. Hence, our study explored the possible causes of a rapid upsurge in COVID-associated mucormycosis, which has accounted for over 70% of global cases. Factors associated with the increase in mucormycosis cases in COVID-19 patients include diabetes mellitus, steroid overdose, high iron levels, and immunosuppression, combined with other possible factors, such as unhygienic conditions, prolonged hospitalization, use of ventilators, and leaky humidifiers in oxygen cylinders. These create an ideal environment for contracting mucormycosis. However, these cases could be reduced by disseminating simple preventive measures and creating awareness among the medical society and general public of this rare and deadly contagion of COVID-associated mucormycosis. The identification of early symptoms will also help to restrict the spread of lethal fungal diseases. Furthermore, a collaborative team of surgeons, ophthalmologists, physicians, and otolaryngologists would be required in the hospital wards to accelerate surgeries on severely impacted patients.Khaiwal RavindraAjit AhlawatElsevierarticleCOVID-19COVID-associated mucormycosisdiabetes mellitussteroid overdoseawarenessInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 112, Iss , Pp 278-280 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 COVID-associated mucormycosis diabetes mellitus steroid overdose awareness Infectious and parasitic diseases RC109-216
spellingShingle	COVID-19 COVID-associated mucormycosis diabetes mellitus steroid overdose awareness Infectious and parasitic diseases RC109-216 Khaiwal Ravindra Ajit Ahlawat Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
description	The second wave of COVID-19 due to the delta variant (B.1.617.2) led to a rapid rise in total coronavirus and COVID-associated mucormycosis cases reported from India. Hence, our study explored the possible causes of a rapid upsurge in COVID-associated mucormycosis, which has accounted for over 70% of global cases. Factors associated with the increase in mucormycosis cases in COVID-19 patients include diabetes mellitus, steroid overdose, high iron levels, and immunosuppression, combined with other possible factors, such as unhygienic conditions, prolonged hospitalization, use of ventilators, and leaky humidifiers in oxygen cylinders. These create an ideal environment for contracting mucormycosis. However, these cases could be reduced by disseminating simple preventive measures and creating awareness among the medical society and general public of this rare and deadly contagion of COVID-associated mucormycosis. The identification of early symptoms will also help to restrict the spread of lethal fungal diseases. Furthermore, a collaborative team of surgeons, ophthalmologists, physicians, and otolaryngologists would be required in the hospital wards to accelerate surgeries on severely impacted patients.
format	article
author	Khaiwal Ravindra Ajit Ahlawat
author_facet	Khaiwal Ravindra Ajit Ahlawat
author_sort	Khaiwal Ravindra
title	Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
title_short	Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
title_full	Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
title_fullStr	Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
title_full_unstemmed	Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
title_sort	five probable factors responsible for the covid-associated mucormycosis outbreak in india
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/5f79c437ea8847149284f53d389a5a76
work_keys_str_mv	AT khaiwalravindra fiveprobablefactorsresponsibleforthecovidassociatedmucormycosisoutbreakinindia AT ajitahlawat fiveprobablefactorsresponsibleforthecovidassociatedmucormycosisoutbreakinindia
_version_	1718406804540489728

Five probable factors responsible for the COVID-associated mucormycosis outbreak in India

Ejemplares similares